165 related articles for article (PubMed ID: 22260017)
1. [Advances in the study of small molecule antagonists of chemokine receptors as anti-asthma agents].
Ji HJ; Hu JF; Chen NH
Yao Xue Xue Bao; 2011 Nov; 46(11):1286-90. PubMed ID: 22260017
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4.
Pease JE; Horuk R
Expert Opin Drug Discov; 2014 May; 9(5):467-83. PubMed ID: 24641500
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor inhibitors as a novel option in treatment of asthma.
Adcock IM; Caramori G
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):257-61. PubMed ID: 15379593
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor antagonists: Part 1.
Pease JE; Horuk R
Expert Opin Ther Pat; 2009 Jan; 19(1):39-58. PubMed ID: 19441897
[TBL] [Abstract][Full Text] [Related]
5. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma.
Tian L; Li W; Wang J; Zhang Y; Zheng Y; Qi H; Guo X; Zhang Y; Ma D; Shen H; Wang Y
Allergy; 2011 Feb; 66(2):287-97. PubMed ID: 21208220
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
Erin EM; Williams TJ; Barnes PJ; Hansel TT
Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):201-14. PubMed ID: 14561201
[TBL] [Abstract][Full Text] [Related]
7. A closer look at chemokines and their role in asthmatic responses.
Smit JJ; Lukacs NW
Eur J Pharmacol; 2006 Mar; 533(1-3):277-88. PubMed ID: 16464446
[TBL] [Abstract][Full Text] [Related]
8. CCR3 blockade as a new therapy for asthma.
Bertrand CP; Ponath PD
Expert Opin Investig Drugs; 2000 Jan; 9(1):43-52. PubMed ID: 11060659
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice.
Carpenter KJ; Ewing JL; Schuh JM; Ness TL; Kunkel SL; Aparici M; Miralpeix M; Hogaboam CM
Br J Pharmacol; 2005 Aug; 145(8):1160-72. PubMed ID: 15951834
[TBL] [Abstract][Full Text] [Related]
10. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma.
Wegmann M; Göggel R; Sel S; Sel S; Erb KJ; Kalkbrenner F; Renz H; Garn H
Am J Respir Cell Mol Biol; 2007 Jan; 36(1):61-7. PubMed ID: 16917075
[TBL] [Abstract][Full Text] [Related]
11. New chemokine targets for asthma therapy.
Garcia G; Godot V; Humbert M
Curr Allergy Asthma Rep; 2005 Mar; 5(2):155-60. PubMed ID: 15683617
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets.
Clemetson KJ; Clemetson JM; Proudfoot AE; Power CA; Baggiolini M; Wells TN
Blood; 2000 Dec; 96(13):4046-54. PubMed ID: 11110672
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2.
Chen H; Xu X; Teng J; Cheng S; Bunjhoo H; Cao Y; Liu J; Xie J; Wang C; Xu Y; Xiong W
Int J Clin Exp Pathol; 2015; 8(6):6700-7. PubMed ID: 26261552
[TBL] [Abstract][Full Text] [Related]
14. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
15. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
Suzaki Y; Hamada K; Nomi T; Ito T; Sho M; Kai Y; Nakajima Y; Kimura H
Eur Respir J; 2008 Apr; 31(4):783-9. PubMed ID: 18094012
[TBL] [Abstract][Full Text] [Related]
16. New therapeutics that modulate chemokine networks.
Schwarz MK; Wells TN
Nat Rev Drug Discov; 2002 May; 1(5):347-58. PubMed ID: 12120410
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-directed therapy in asthma.
Ichinose M; Barnes PJ
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptors in allergic diseases.
Castan L; Magnan A; Bouchaud G
Allergy; 2017 May; 72(5):682-690. PubMed ID: 27864967
[TBL] [Abstract][Full Text] [Related]
19. Chemokines and their receptors as potential targets for the treatment of asthma.
Palmqvist C; Wardlaw AJ; Bradding P
Br J Pharmacol; 2007 Jul; 151(6):725-36. PubMed ID: 17471178
[TBL] [Abstract][Full Text] [Related]
20. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
